Neuropsychopharmacology - Table of Contents alert Volume 39 Issue 3

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 39, Issue 3 (February 2014) In this issue Review Original Articles Corrigendum Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement The latest NPP podcast is now available!  Neuropsychopharmacology Reviews: Biomolecular Discovery: Mechanisms, Therapeutics, and Biomarkers in Neural Disorders In this podcast the editors editors of this year's NPPR volume, Carol Nilsson and Kathryn Cunningham, provide an overview of the topic.  Listen to the podcast for FREE  Review Top Learning not to Fear: Neural Correlates of Learned Safety Eryan Kong, Francisco J Monje, Joy Hirsch and Daniela D Pollak Neuropsychopharmacology 2014 39: 515-527; advance online publication, August 21, 2013; 10.1038/npp.2013.191 Abstract | Full Text Original Articles Top N-Glycosylation of GABAA Receptor Subunits is Altered in Schizophrenia Toni Marie Mueller, Vahram Haroutunian and James H Meador-Woodruff Neuropsychopharmacology 2014 39: 528-537; advance online publication, August 6, 2013; 10.1038/npp.2013.190 Abstract | Full Text ΔFosB Induction in Prefrontal Cortex by Antipsychotic Drugs is Associated with Negative Behavioral Outcomes David M Dietz, Pamela J Kennedy, HaoSheng Sun, Ian Maze, Amy M Gancarz, Vincent Vialou, Ja Wook Koo, Ezekiell Mouzon, Subroto Ghose, Carol A Tamminga and Eric J Nestler Neuropsychopharmacology 2014 39: 538-544; advance online publication, September 26, 2013; 10.1038/npp.2013.255 Abstract | Full Text Neural Correlates of Reward-Based Spatial Learning in Persons with Cocaine Dependence Gregory Z Tau, Rachel Marsh, Zhishun Wang, Tania Torres-Sanchez, Barbara Graniello, Xuejun Hao, Dongrong Xu, Mark G Packard, Yunsuo Duan, Alayar Kangarlu, Diana Martinez and Bradley S Peterson Neuropsychopharmacology 2014 39: 545-555; advance online publication, August 6, 2013; 10.1038/npp.2013.189 Abstract | Full Text Transient Downregulation of Dab1 Protein Levels during Development Leads to Behavioral and Structural Deficits: Relevance for Psychiatric Disorders Catia M Teixeira, Nuria Masachs, Ashraf Muhaisen, Carles Bosch, Javier Pérez-Martínez, Brian Howell and Eduardo Soriano Neuropsychopharmacology 2014 39: 556-568; advance online publication, September 13, 2013; 10.1038/npp.2013.226 Abstract | Full Text Cocaine-Induced Changes of Synaptic Transmission in the Striatum are Modulated by Adenosine A2A Receptors and Involve the Tyrosine Phosphatase STEP Valentina Chiodi, Cinzia Mallozzi, Antonella Ferrante, Jiang F Chen, Paul J Lombroso, Anna Maria Michela Di Stasi, Patrizia Popoli and Maria Rosaria Domenici Neuropsychopharmacology 2014 39: 569-578; advance online publication, August 30, 2013; 10.1038/npp.2013.229 Abstract | Full Text Repeated Binge-Like Ethanol Drinking Alters Ethanol Drinking Patterns and Depresses Striatal GABAergic Transmission OPEN Mark V Wilcox, Verginia C Cuzon Carlson, Nyssa Sherazee, Gretchen M Sprow, Roland Bock, Todd E Thiele, David M Lovinger and Veronica A Alvarez Neuropsychopharmacology 2014 39: 579-594; advance online publication, September 2, 2013; 10.1038/npp.2013.230 Abstract | Full Text Dietary Tyrosine/Phenylalanine Depletion Effects on Behavioral and Brain Signatures of Human Motivational Processing James M Bjork, Steven J Grant, Gang Chen and Daniel W Hommer Neuropsychopharmacology 2014 39: 595-604; advance online publication, September 2, 2013; 10.1038/npp.2013.232 Abstract | Full Text Leptin Signaling in the Medial Nucleus Tractus Solitarius Reduces Food Seeking and Willingness to Work for Food Scott E Kanoski, Amber L Alhadeff, Samantha M Fortin, Jennifer R Gilbert and Harvey J Grill Neuropsychopharmacology 2014 39: 605-613; advance online publication, September 4, 2013; 10.1038/npp.2013.235 Abstract | Full Text Pain-Related Depression of the Mesolimbic Dopamine System in Rats: Expression, Blockade by Analgesics, and Role of Endogenous κ-opioids Michael D Leitl, Sara Onvani, M Scott Bowers, Kejun Cheng, Kenner C Rice, William A Carlezon, Jr, Matthew L Banks and S Stevens Negus Neuropsychopharmacology 2014 39: 614-624; advance online publication, September 6, 2013; 10.1038/npp.2013.236 Abstract | Full Text Potentiation of GluN2C/D NMDA Receptor Subtypes in the Amygdala Facilitates the Retention of Fear and Extinction Learning in Mice Kevin K Ogden, Alpa Khatri, Stephen F Traynelis and Scott A Heldt Neuropsychopharmacology 2014 39: 625-637; advance online publication, September 6, 2013; 10.1038/npp.2013.241 Abstract | Full Text 7,8-Dihydroxyflavone Prevents Synaptic Loss and Memory Deficits in a Mouse Model of Alzheimer’s Disease Zhentao Zhang, Xia Liu, Jason P Schroeder, Chi-Bun Chan, Mingke Song, Shan Ping Yu, David Weinshenker and Keqiang Ye Neuropsychopharmacology 2014 39: 638-650; advance online publication, September 11, 2013; 10.1038/npp.2013.243 Abstract | Full Text Meclizine Enhancement of Sensorimotor Gating in Healthy Male Subjects with High Startle Responses and Low Prepulse Inhibition José A Larrauri, Lisalynn D Kelley, Mason R Jenkins, Eric C Westman, Nestor A Schmajuk, M Zachary Rosenthal and Edward D Levin Neuropsychopharmacology 2014 39: 651-659; advance online publication, September 18, 2013; 10.1038/npp.2013.248 Abstract | Full Text Contribution of a Mesocorticolimbic Subcircuit to Drug Context-Induced Reinstatement of Cocaine-Seeking Behavior in Rats Heather C Lasseter, Xiaohu Xie, Amy A Arguello, Audrey M Wells, Matthew A Hodges and Rita A Fuchs Neuropsychopharmacology 2014 39: 660-669; advance online publication, September 20, 2013; 10.1038/npp.2013.249 Abstract | Full Text Cumulative Adversity Sensitizes Neural Response to Acute Stress: Association with Health Symptoms Dongju Seo, Kristen A Tsou, Emily B Ansell, Marc N Potenza and Rajita Sinha Neuropsychopharmacology 2014 39: 670-680; advance online publication, September 20, 2013; 10.1038/npp.2013.250 Abstract | Full Text Quantitative Prediction of Individual Psychopathology in Trauma Survivors Using Resting-State fMRI OPEN Qiyong Gong, Lingjiang Li, Mingying Du, William Pettersson-Yeo, Nicolas Crossley, Xun Yang, Jing Li, Xiaoqi Huang and Andrea Mechelli Neuropsychopharmacology 2014 39: 681-687; advance online publication, September 25, 2013; 10.1038/npp.2013.251 Abstract | Full Text Neural Correlates of Alcohol-Approach Bias in Alcohol Addiction: the Spirit is Willing but the Flesh is Weak for Spirits Corinde E Wiers, Christine Stelzel, Soyoung Q Park, Christiane K Gawron, Vera U Ludwig, Stefan Gutwinski, Andreas Heinz, Johannes Lindenmeyer, Reinout W Wiers, Henrik Walter and Felix Bermpohl Neuropsychopharmacology 2014 39: 688-697; advance online publication, September 20, 2013; 10.1038/npp.2013.252 Abstract | Full Text Oxytocin Promotes Facial Emotion Recognition and Amygdala Reactivity in Adults with Asperger Syndrome Gregor Domes, Ekkehardt Kumbier, Markus Heinrichs and Sabine C Herpertz Neuropsychopharmacology 2014 39: 698-706; advance online publication, September 26, 2013; 10.1038/npp.2013.254 Abstract | Full Text Increased Extracellular Glutamate In the Nucleus Accumbens Promotes Excessive Ethanol Drinking in Ethanol Dependent Mice William C Griffin III, Harold L Haun, Callan L Hazelbaker, Vorani S Ramachandra and Howard C Becker Neuropsychopharmacology 2014 39: 707-717; advance online publication, September 26, 2013; 10.1038/npp.2013.256 Abstract | Full Text Cerebellar Morphology and the Effects of Stimulant Medications in Youths with Attention Deficit-Hyperactivity Disorder Iliyan Ivanov, James W Murrough, Ravi Bansal, Xuejun Hao and Bradley S Peterson Neuropsychopharmacology 2014 39: 718-726; advance online publication, September 27, 2013; 10.1038/npp.2013.257 Abstract | Full Text Neurosteroid Agonist at GABAA Receptor Induces Persistent Neuroplasticity in VTA Dopamine Neurons Elena Vashchinkina, Aino K Manner, Olga Vekovischeva, Bjørnar den Hollander, Mikko Uusi-Oukari, Teemu Aitta-aho and Esa R Korpi Neuropsychopharmacology 2014 39: 727-737; advance online publication, September 27, 2013; 10.1038/npp.2013.258 Abstract | Full Text Hippocampal and Amygdalar Volumetric Differences in Pathological Gambling: a Preliminary Study of the Associations with the Behavioral Inhibition System Ardeshir S Rahman, Jiansong Xu and Marc N Potenza Neuropsychopharmacology 2014 39: 738-745; advance online publication, September 27, 2013; 10.1038/npp.2013.260 Abstract | Full Text STAT1 Negatively Regulates Spatial Memory Formation and Mediates the Memory-Impairing Effect of Aβ OPEN Wei-Lun Hsu, Yun-Li Ma, Ding-You Hsieh, Yen-Chen Liu and Eminy HY Lee Neuropsychopharmacology 2014 39: 746-758; advance online publication, September 30, 2013; 10.1038/npp.2013.263 Abstract | Full Text Disruption of Glutamate Receptor-Interacting Protein in Nucleus Accumbens Enhances Vulnerability to Cocaine Relapse Lisa A Briand, Blake A Kimmey, Pavel I Ortinski, Richard L Huganir and R Christopher Pierce Neuropsychopharmacology 2014 39: 759-769; advance online publication, October 15, 2013; 10.1038/npp.2013.265 Abstract | Full Text Association of Depressive Symptoms with Hippocampal Volume in 1936 Adults E Sherwood Brown, Carroll W Hughes, Roderick McColl, Ronald Peshock, Kevin S King and A John Rush Neuropsychopharmacology 2014 39: 770-779; advance online publication, October 4, 2013; 10.1038/npp.2013.271 Abstract | Full Text Corrigendum Top Loss of Environmental Enrichment Increases Vulnerability to Cocaine Addiction Joelle Nader, Chauvet Claudia, Rana El Rawas, Laure Favot, Mohamed Jaber, Nathalie Thiriet and Marcello Solinas Neuropsychopharmacology 2014 39: 780; 10.1038/npp.2013.303 Full Text Advertisement Latest Neuropsychopharmacology Reviews issue The 2014 issue of Neuropsychopharmacology Reviews is entitled Biomolecular Discovery: Mechanisms, Therapeutics, and Biomarkers in Neural Disorders. The articles in this issue focus on recent advances in the detection, subtyping and monitoring of complex neural disease progression, the definition of new molecular targets for therapeutic intervention and biomarkers, with an emphasis on the use of genome-wide analytical technologies. Read the issue here  Please note that you need to be a subscriber or site-license holder to enjoy full-text access to Neuropsychopharmacology. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2014 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.